AirSculpt Technologies, Inc. reported its financial results for the second quarter of 2026, revealing a revenue of $42.9 million, a decrease of approximately 2.5% from $44.0 million in the same period of 2025. For the first half of 2026, the company generated $82.3 million in revenue, down 1.3% from $83.4 million year-over-year. The decline in revenue was attributed to a 2.0% decrease in average selling price on a same-center basis, partially offset by a 1.0% increase in same-center case volume. The company performed 3,376 cases in the second quarter, slightly down from 3,392 cases in the prior year.
Operating expenses for the second quarter totaled $42.9 million, a marginal decrease from $43.2 million in the previous year. The cost of services decreased by 3.7% to $16.6 million, while selling, general, and administrative expenses rose by 3.3% to $23.4 million, primarily due to increased advertising costs. The net loss for the quarter was $1.1 million, compared to a loss of $591,000 in the same quarter of 2025. The loss per share was $(0.02), compared to $(0.01) in the prior year.
In terms of strategic developments, AirSculpt has expanded its operational footprint, now operating 31 centers across 20 states and Canada. The company has also engaged in an at-the-market offering program, generating approximately $19.6 million in net proceeds during the first half of 2026. This funding is intended to support ongoing operations and debt repayment, as the company made significant principal payments on its term loans, reducing total debt to $43.6 million as of June 30, 2026.
The company reported a cash balance of $18.8 million at the end of the second quarter, a significant increase from $8.2 million at the same time last year. This improvement in liquidity is attributed to the successful execution of its capital-raising strategies. However, the company also noted that it is facing challenges related to market conditions and competition in the weight loss and obesity solutions market, which could impact future performance.
Looking ahead, AirSculpt anticipates continued focus on enhancing operational efficiencies and expanding its market presence. The company is committed to addressing identified weaknesses in its internal controls over financial reporting and is actively working on remediation plans. Management believes that the cash generated from operations will be sufficient to meet working capital requirements and liquidity obligations for at least the next 12 months, although they acknowledge the potential for fluctuations in performance due to external factors.
About Airsculpt Technologies, Inc.
AirSculpt Technologies, Inc. specializes in minimally invasive body contouring procedures that remove fat and tighten skin without needles, scalpels, stitches, or general anesthesia. Its proprietary AirSculpt® method offers customized fat removal and fat transfer treatments, including the Power BBL®, Up a Cup™, and Hip Flip®. Serving primarily affluent metropolitan and suburban markets across the U.S., Canada, and the U.K., AirSculpt delivers premium patient experiences through surgeon-led care in spa-like centers, operating on a private-pay, scalable business model.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov